HansBiomed Corporation Capital Reinvestment Ratio
HansBiomed Corporation capital reinvestment ratio. HansBiomed Corporation (042520) has a Capital Reinvestment Ratio of 0.37x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩1.21 Billion) in capital expenditures (₩448.85 Million). Check 042520 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of HansBiomed Corporation (2012–2025)
Capital reinvestment ratio of HansBiomed Corporation from 2012 to 2025. This chart tracks HansBiomed Corporation's Capital Reinvestment Ratio across 10 annual periods. Also explore HansBiomed Corporation (042520) equity growth momentum to track the company's year-over-year net asset growth rate.
HansBiomed Corporation Capital Reinvestment Ratio by Year (2012–2025)
HansBiomed Corporation capital reinvestment ratio by year from 2012 to 2025. For the full cash flow conversion analysis, see 042520 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 5.52x | ₩318.34 Million | ₩1.76 Billion | ▲ +243.2% |
| 2024 | 1.61x | ₩1.76 Billion | ₩2.83 Billion | ▲ +31.3% |
| 2020 | 1.23x | ₩5.75 Billion | ₩7.05 Billion | ▼ -39.3% |
| 2019 | 2.02x | ₩7.71 Billion | ₩15.56 Billion | ▲ +368.7% |
| 2018 | 0.43x | ₩5.20 Billion | ₩2.24 Billion | ▼ -81.5% |
| 2017 | 2.33x | ₩5.60 Billion | ₩13.05 Billion | ▲ +33.1% |
| 2015 | 1.75x | ₩3.47 Billion | ₩6.07 Billion | ▼ -70.9% |
| 2014 | 6.01x | ₩2.06 Billion | ₩12.39 Billion | ▲ +92.3% |
| 2013 | 3.13x | ₩2.33 Billion | ₩7.29 Billion | ▲ +1750.5% |
| 2012 | 0.17x | ₩1.50 Billion | ₩253.56 Million | — |